Loading insider details...
Latest Form 4 (Jun 23, 2026): Grant/Award of 95,400 ALLO shares.
Every alert includes an AI-written analysis of the filing, plus news and market context.
| Filed | Company | Transaction | Shares | Value |
|---|---|---|---|---|
| Jun 23, 2026 | Allogene Therapeutics, Inc. (ALLO) | Grant/Award | 95,400 | n/a |
| Feb 19, 2026 | UroGen Pharma Ltd. (URGN) | Grant/Award | 153,195 | n/a |
| Jul 30, 2025 | UroGen Pharma Ltd. (URGN) | Grant/Award | 87,615 | n/a |
| Jun 24, 2025 | Allogene Therapeutics, Inc. (ALLO) | Grant/Award | 95,400 | n/a |
| Feb 4, 2025 | UroGen Pharma Ltd. (URGN) | Grant/Award | 96,377 | n/a |
| Jun 7, 2024 | Allogene Therapeutics, Inc. (ALLO) | Grant/Award | 191,082 | n/a |
| Feb 3, 2024 | UroGen Pharma Ltd. (URGN) | Grant/Award | 87,615 | n/a |
| Jun 15, 2023 | Allogene Therapeutics, Inc. (ALLO) | Grant/Award | 116,120 | n/a |
| Feb 2, 2023 | UroGen Pharma Ltd. (URGN) | Exercise/Conversion | 5,000 | n/a |
| Jun 17, 2022 | Allogene Therapeutics, Inc. (ALLO) | Grant/Award | 71,070 | n/a |